Skip to main content

Articles

Page 1 of 18

  1. Overdose deaths continue to rise within the United States, despite effective treatments such as buprenorphine and methadone for opioid use disorder (OUD). Mobile medical units with the ability to dispense bupr...

    Authors: Sarah E. Messmer, Abigail T. Elmes, Alexander F. Infante, Anna Patterson, Mackenzie Smith, Albert Leon Murphy, Antonio D. Jimenez, Stockton Mayer, Dennis P. Watson, Kevin Whitfield, Steven J. Fisher and Jennie B. Jarrett
    Citation: Addiction Science & Clinical Practice 2024 19:53
  2. Cigarette smoking remains a leading cause of preventable illness and death, underscoring the need for effective evidence-based smoking cessation interventions. Nuumi, a novel smoking cessation program integrat...

    Authors: Helen Schiek, Tobias Esch, Maren M. Michaelsen and Cosima Hoetger
    Citation: Addiction Science & Clinical Practice 2024 19:52
  3. Clinic-based interventions are needed to promote successful direct acting antiviral (DAA) treatment for chronic hepatitis C virus (HCV) infection in patients with substance use disorders (SUDs) among rural Vet...

    Authors: Mary Jane Burton, Andrew C. Voluse and Amee B. Patel
    Citation: Addiction Science & Clinical Practice 2024 19:51
  4. Buprenorphine is an effective and safe treatment for opioid use disorder, but the requirement for moderate opioid withdrawal symptoms to emerge prior to initiation is a significant treatment barrier.

    Authors: Pouya Azar, Hannah Schneiderman, Henry Barron, James S. H. Wong, Maximilian Meyer, Dayyon Newman-Azar, Matin Narimani, Martha J. Ignaszewski, Nickie Mathew, Rodney Mullen, Reinhard M. Krausz and Anil R. Maharaj
    Citation: Addiction Science & Clinical Practice 2024 19:50
  5. The 15-method is a targeted screening and treatment approach for alcohol problems in primary care. The 15-method used in primary care has proven as effective as specialized treatment for mild to moderate alcoh...

    Authors: Peter Næsborg Schøler, Kristina Hasselbalch Volke, Sven Andréasson, Sanne Rasmussen, Jens Søndergaard and Anette Søgaard Nielsen
    Citation: Addiction Science & Clinical Practice 2024 19:49
  6. Regulations put in place to protect the privacy of individuals receiving substance use disorder (SUD) treatment have resulted in an unintended consequence of siloed SUD treatment and referral information outsi...

    Authors: Alexandra R. Tillman, Emily Bacon, Brooke Bender, Dean McEwen, Joshua Blum, Matthew Hoag, Kenneth A. Scott, Rachel Everhart, Rebecca Hanratty, Laura J. Podewils, Carolina Close, John Mills and Arthur J. Davidson
    Citation: Addiction Science & Clinical Practice 2024 19:48
  7. Women who engage in sex work and use drugs (WSWUD) experience disproportionate HIV risks. Substance use treatment bridge clinics offer an opportunity to increase HIV pre-exposure prophylaxis (PrEP) delivery to...

    Authors: Miriam TH Harris, Emma Weinberger, Christine O’Brien, Mary Althoff, Samantha Paltrow-Krulwich, Jessica L. Taylor, Abigail Judge, Jeffrey H. Samet, Alexander Y. Walley and Christine M. Gunn
    Citation: Addiction Science & Clinical Practice 2024 19:47
  8. Implementation of pre-exposure prophylaxis (PrEP) to prevent HIV transmission is suboptimal in the United States, particularly among people who use drugs (PWUD). PrEP research among PWUD is scarce, and the fac...

    Authors: James L. Merle, Juan P. Zapata, Artur Quieroz, Alithia Zamantakis, Olutobi Sanuade, Brian Mustanski and Justin D. Smith
    Citation: Addiction Science & Clinical Practice 2024 19:46
  9. Supervised injectable opioid treatment (SIOT) is a promising alternative for people living with opioid use disorder (OUD) who have not sufficiently benefitted from oral opioid substitution treatment. Yet, SIOT...

    Authors: Zoe Friedmann, Hans-Tilmann Kinkel, Claudia Kühner, Andreas Zsolnai, Annette Binder and Inge Mick
    Citation: Addiction Science & Clinical Practice 2024 19:45
  10. Norway has a growing proportion of ageing opioid agonist treatment (OAT) patients, with 42% of the 8300 Norwegian OAT patients aged over 50 in 2022. This study aims to explore practitioners’ views and experien...

    Authors: John Todd-Kvam and Thomas Clausen
    Citation: Addiction Science & Clinical Practice 2024 19:44
  11. Delivering methadone treatment in community health facilities by primary care providers is a task-shifting strategy to expand access to drug use treatment, especially in rural mountainous areas. This study aim...

    Authors: Bich Diep Nguyen, Li Li, Chunqing Lin, Thu Trang Nguyen, Steven Shoptaw and Minh Giang Le
    Citation: Addiction Science & Clinical Practice 2024 19:43
  12. To assess the extent of Coronavirus-related disruption to health and social care treatment and social interactions among people with lived or living experience of substance use in Scotland, and explore potenti...

    Authors: Mark McCann, Federica Bianchi, Srebrenka Letina, Samantha Stewart, Katy McLeod and Mark Tranmer
    Citation: Addiction Science & Clinical Practice 2024 19:42
  13. Alcohol-attributable medical disorders are prevalent among individuals with alcohol use disorder (AUD). However, there is a lack of research on prescriptions of pharmacological treatment for AUD in those with ...

    Authors: Anastasia Månsson, Anna-Karin Danielsson, Hugo Sjöqvist, Toivo Glatz, Andreas Lundin and Sara Wallhed Finn
    Citation: Addiction Science & Clinical Practice 2024 19:41
  14. People with substance use disorders (SUDs) have restricted engagement with health-care facilities and describe repeated experiences of stigma, discrimination, and mistreatment when receiving care at health-car...

    Authors: Maryam Khazaee-Pool, Seyed Abolhassan Naghibi, Tahereh Pashaei and Koen Ponnet
    Citation: Addiction Science & Clinical Practice 2024 19:40
  15. Injection Drug use is associated with increased HIV risk behaviour that may result in the transmission of HIV and poor access to HIV prevention and treatment. In 2020, Uganda introduced the ‘medication for opi...

    Authors: Peter Mudiope, Brian Byamah Mutamba, Liz Komuhangi, Joan Nangendo, Stella Alamo, Bradley Mathers, Fredrick Makumbi and Rhoda Wanyenze
    Citation: Addiction Science & Clinical Practice 2024 19:39
  16. Children at risk of substance use disorders (SUD) should be detected using brief structured tools for early intervention. This study sought to translate and adapt the Car, Relax, Alone, Forget, Family/Friends,...

    Authors: Joyce Sserunjogi Nalugya, Ingunn Marie Stadskleiv Engebretsen, Noeline Nakasujja, Grace Ndeezi, Juliet N. Babirye, Victoria Bakken, Ane-Marthe Solheim Skar, James K. Tumwine and Norbert Skokauskas
    Citation: Addiction Science & Clinical Practice 2024 19:38
  17. Knowledge of co-occurring mental disorders (termed ‘dual diagnosis’) among patients receiving opioid agonist treatment (OAT) is scarce. This study aimed (1) to estimate the prevalence and structure of dual dia...

    Authors: Gabriela Rolová, Svetlana Skurtveit, Roman Gabrhelík, Viktor Mravčík and Ingvild Odsbu
    Citation: Addiction Science & Clinical Practice 2024 19:37
  18. Digital technologies have positively impacted the availability and usability of clinical algorithms through the advancement in mobile health. Therefore, this study aimed to determine if a web-based algorithm d...

    Authors: Irene Tamí-Maury, Samuel Tundealao, Valeri Noé-Díaz, Esperanza Garcia, Vilma Diaz, Jennie Meier, Mira Dani and Tatiana Vidaurre
    Citation: Addiction Science & Clinical Practice 2024 19:36
  19. As the return to alcohol use in individuals with alcohol use disorder (AUD) is common during treatment and recovery, it is important that abstinence motivation is maintained after such critical incidences. Our...

    Authors: Catharina Lang, Kiona K. Weisel, Sebastian Saur, Lukas M. Fuhrmann, Antonie Schoenleber, Daniela Reichl, Niklas Enewoldsen, Sabine Steins-Loeber and Matthias Berking
    Citation: Addiction Science & Clinical Practice 2024 19:35
  20. Individuals with substance use disorders (SUDs) frequently use acute hospital services. The Navigation Services to Avoid Rehospitalization (NavSTAR) trial found that a patient navigation intervention for hospi...

    Authors: Courtney D. Nordeck, Sharon M. Kelly, Robert P. Schwartz, Shannon G. Mitchell, Christopher Welsh, Kevin E. O’Grady and Jan Gryczynski
    Citation: Addiction Science & Clinical Practice 2024 19:33
  21. Health care providers are a key source of reports of infants to child welfare related to birthing people’s substance use. Many of these reports are overreports, or reports that exceed what is legally mandated,...

    Authors: Sarah C. M. Roberts, Kimá Joy Taylor, Karen Alexander, Daisy Goodman, Noelle Martinez and Mishka Terplan
    Citation: Addiction Science & Clinical Practice 2024 19:32
  22. Hospitalization presents an opportunity to begin people with opioid use disorder (OUD) on medications for opioid use disorder (MOUD) and link them to care after discharge; regrettably, people admitted to the h...

    Authors: Sandra K. Evans, Allison J. Ober, Ariella R. Korn, Alex Peltz, Peter D. Friedmann, Kimberly Page, Cristina Murray-Krezan, Sergio Huerta, Stephen J. Ryzewicz, Lina Tarhuni, Teryl K. Nuckols, Katherine E. Watkins and Itai Danovitch
    Citation: Addiction Science & Clinical Practice 2024 19:31
  23. Alcohol misuse is common and causes substantial harm. Internet-delivered cognitive behaviour therapy (ICBT) is effective in reducing alcohol misuse; however, the literature investigating how treatment outcomes...

    Authors: Ram P. Sapkota, Tristen Lozinski, Andrew Wilhems, Marcie Nugent, Michael P. Schaub, Matthew T. Keough, Christopher Sundström and Heather D. Hadjistavropoulos
    Citation: Addiction Science & Clinical Practice 2024 19:30
  24. Hospitalizations involving opioid use disorder (OUD) are increasing. Medications for opioid use disorder (MOUD) reduce mortality and acute care utilization. Hospitalization is a reachable moment for initiating...

    Authors: Gavin Bart, P. Todd Korthuis, Julie M. Donohue, Hildi J. Hagedorn, Dave H. Gustafson, Angela R. Bazzi, Eva Enns, Jennifer McNeely, Udi E. Ghitza, Kara M. Magane, Paulette Baukol, Ashley Vena, Jacklyn Harris, Delia Voronca and Richard Saitz
    Citation: Addiction Science & Clinical Practice 2024 19:29
  25. Substance use disorder (SUD) is associated with executive function (EF) deficits and sensory modulation dysfunction (SMD). Yet, these deficits are not addressed therapeutically. This study aims to examine the ...

    Authors: Naama Assayag, Tami Bar-Shalita and Debbie Rand
    Citation: Addiction Science & Clinical Practice 2024 19:28
  26. Pharmacy-based screening and brief interventions (SBI) offer opportunities to identify opioid misuse and opioid safety risks and provide brief interventions that do not overly burden pharmacists. Currently, su...

    Authors: Deepika Rao, James H. Ford and Olayinka O. Shiyanbola
    Citation: Addiction Science & Clinical Practice 2024 19:27
  27. Emergency departments (ED) are incorporating Peer Support Specialists (PSSs) to help with patient care for substance use disorders (SUDs). Despite rapid growth in this area, little is published regarding workf...

    Authors: Lindsey K Jennings, Laura Lander, Tricia Lawdahl, Erin A. McClure, Angela Moreland, Jenna L. McCauley, Louise Haynes, Timothy Matheson, Richard Jones, Thomas E. Robey, Sarah Kawasaki, Phillip Moschella, Amer Raheemullah, Suzette Miller, Gina Gregovich, Deborah Waltman…
    Citation: Addiction Science & Clinical Practice 2024 19:26
  28. Long-acting injectable buprenorphine (LAIB) formulations are a novel treatment approach in opioid agonist treatment (OAT), which provide patients with a steady dose administered weekly or monthly and thus redu...

    Authors: Johan Nordgren, Bodil Monwell, Björn Johnson, Nina Veetnisha Gunnarsson and Andrea Johansson Capusan
    Citation: Addiction Science & Clinical Practice 2024 19:25
  29. The Cannabis Abuse Screening Test (CAST) is a widely used screening tool for identifying patterns of cannabis use that have negative health or social consequences for both the user and others involved. This br...

    Authors: Hicham El Malki, Salma Ghofrane Moutawakkil, Abdelfettah El-Ammari, Mohammed El Amine Ragala, Jaouad El Hilaly, Samir El Gnaoui, Fatima El Houari, Karima El Rhazi and Btissame Zarrouq
    Citation: Addiction Science & Clinical Practice 2024 19:24
  30. Communities That HEAL (CTH) is a novel, data-driven community-engaged intervention designed to reduce opioid overdose deaths by increasing community engagement, adoption of an integrated set of evidence-based ...

    Authors: Iván D. Montoya, Colleen Watson, Arnie Aldridge, Danielle Ryan, Sean M. Murphy, Brenda Amuchi, Kathryn E. McCollister, Bruce R. Schackman, Joshua L. Bush, Drew Speer, Kristin Harlow, Stephen Orme, Gary A. Zarkin, Mathieu Castry, Eric E. Seiber, Joshua A. Barocas…
    Citation: Addiction Science & Clinical Practice 2024 19:23
  31. Hospitalization is a “reachable moment” for people who inject drugs (PWID), but preventive care including HIV testing, prevention and treatment is rarely offered within inpatient settings.

    Authors: William Bradford, Hana Akselrod, John Bassler, Kelly W. Gagnon, Greer Burkholder, Joseph Edward Carpenter, Alaina Steck, Jillian Catalanotti, Irene Kuo, Keanan McGonigle, William Mai, Melissa Notis, Christopher Brokus, Sarah Kattakuzhy, Elana Rosenthal and Ellen F. Eaton
    Citation: Addiction Science & Clinical Practice 2024 19:22
  32. People who inject drugs (PWID) remain a high priority population under the federal Ending the HIV Epidemic initiative with 11% of new HIV infections attributable to injection drug use. There is a critical need...

    Authors: Tyler S. Bartholomew, Marina Plesons, David P. Serota, Elizabeth Alonso, Lisa R. Metsch, Daniel J. Feaster, Jessica Ucha, Edward Suarez Jr., David W. Forrest, Teresa A. Chueng, Katrina Ciraldo, Jimmie Brooks, Justin D. Smith, Joshua A. Barocas and Hansel E. Tookes
    Citation: Addiction Science & Clinical Practice 2024 19:21
  33. Amidst increasing opioid-related fatalities in adolescents and young adults (AYA), there is an urgent need to enhance the quality and availability of developmentally appropriate, evidence-based treatments for ...

    Authors: Melissa Pielech, Crosby Modrowski, Jasper Yeh, Melissa A. Clark, Brandon D. L. Marshall, Francesca L. Beaudoin, Sara J. Becker and Robert Miranda Jr.
    Citation: Addiction Science & Clinical Practice 2024 19:20
  34. Alcohol-associated liver disease is currently the leading cause of liver transplantation and liver deaths both in Europe and the United States. Efficacious treatments exist for alcohol use disorder, but they a...

    Authors: Lamia Y. Haque, Paola Zuluaga, Robert Muga and Daniel Fuster
    Citation: Addiction Science & Clinical Practice 2024 19:19
  35. Pharmacists remain an underutilized resource in the treatment of opioid use disorder (OUD). Although studies have engaged pharmacists in dispensing medications for OUD (MOUD), few studies have evaluated collab...

    Authors: Bethany McLeman, Phoebe Gauthier, Laurie S. Lester, Felicity Homsted, Vernon Gardner III, Sarah K. Moore, Paul J. Joudrey, Lisa Saldana, Gerald Cochran, Jacklyn P. Harris, Kathryn Hefner, Edward Chongsi, Kimberly Kramer, Ashley Vena, Rebecca A. Ottesen, Tess Gallant…
    Citation: Addiction Science & Clinical Practice 2024 19:18
  36. Potential differences in buprenorphine treatment outcomes across various treatment settings are poorly characterized in multi-state administrative data. We thus evaluated the association of opioid use disorder...

    Authors: Kevin Y. Xu, Alex K. Gertner, Shelly F. Greenfield, Arthur Robin Williams and Richard A. Grucza
    Citation: Addiction Science & Clinical Practice 2024 19:17
  37. The feasibility of precision smoking treatment in socioeconomically disadvantaged communities has not been studied.

    Authors: Scott S. Lee, Nicole Senft Everson, Maureen Sanderson, Rebecca Selove, William J. Blot, Stephen King, Karen Gilliam, Suman Kundu, Mark Steinwandel, Sarah J. Sternlieb, Qiuyin Cai, Shaneda Warren Andersen, Debra L. Friedman, Erin Connors Kelly, Mary Kay Fadden, Matthew S. Freiberg…
    Citation: Addiction Science & Clinical Practice 2024 19:16
  38. The ED Leads program was introduced to 11 emergency departments (EDs) within New York City public hospitals from 2018 to 2019 to address a need for addiction support services in the ED. The purpose of this stu...

    Authors: Lynsey Avalone, Monique Lalane, Carla King, Kayna Pfeiffer, Rebecca Linn-Walton and Charles Barron
    Citation: Addiction Science & Clinical Practice 2024 19:15
  39. The prevalence and associated overdose death rates from opioid use disorder (OUD) have dramatically increased in the last decade. Despite more available treatments than 20 years ago, treatment access and high ...

    Authors: A. John Rush, Robert E. Gore-Langton, Gavin Bart, Katharine A. Bradley, Cynthia I. Campbell, James McKay, David W. Oslin, Andrew J. Saxon, T. John Winhusen, Li-Tzy Wu, Landhing M. Moran and Betty Tai
    Citation: Addiction Science & Clinical Practice 2024 19:14
  40. People who inject drugs (PWID) are at increased risk of HIV acquisition and often encounter barriers to accessing healthcare services. Uganda has high HIV prevalence among PWID and lacks integrated pre-exposur...

    Authors: Brenda Kamusiime, Kristin Beima-Sofie, Nok Chhun, Alisaati Nalumansi, Grace Kakoola Nalukwago, Vicent Kasiita, Chris Collins Twesige, Ritah Kansiime, Timothy R. Muwonge, Peter Kyambadde, Herbert Kadama, Peter Mudiope, Sara Glick, Barrot Lambdin, Andrew Mujugira and Renee Heffron
    Citation: Addiction Science & Clinical Practice 2024 19:13
  41. Research is lacking on predictors of outcome for the treatment of alcohol use disorder (AUD) with a goal of controlled drinking (CD). The aim of the study was to investigate one-year outcomes of an RCT, invest...

    Authors: Stina Ingesson-Hammarberg, Nitya Jayaram-Lindström and Anders Hammarberg
    Citation: Addiction Science & Clinical Practice 2024 19:12
  42. Non-profit hospitals in the U.S. are required by the 2010 Patient Protection and Affordable Care Act (ACA) to conduct a community health needs assessment (CHNA) every three years and to formulate an implementa...

    Authors: Cory E. Cronin, Luke Kubacki, Lauren Donovan, Neeraj Puro, Dakota Lavinder, Kristin Schuller and Berkeley Franz
    Citation: Addiction Science & Clinical Practice 2024 19:11
  43. Implementation of medications for opioid use disorder (MOUD) in jails varies by facility and across states. Organizational climate, including staff attitudes toward change and exposure to education, can influe...

    Authors: Pryce S. Michener, Elizabeth A. Evans, Warren J. Ferguson and Peter D. Friedmann
    Citation: Addiction Science & Clinical Practice 2024 19:10
  44. This study aimed to synthetize the evidence on the effectiveness of harm minimization interventions on reducing blood-borne infection transmission and injecting behaviors among people who inject drugs (PWID) t...

    Authors: Fernanda S. Tonin, Filipa Alves da Costa and Fernando Fernandez-Llimos
    Citation: Addiction Science & Clinical Practice 2024 19:9
  45. The opioid epidemic has resulted in expanded substance use treatment services and strained the clinical workforce serving people with opioid use disorder. Focusing on evidence-based counseling practices like m...

    Authors: K. Michelle Peavy, Angela Klipsch, Christina S. Soma, Brian Pace, Zac E. Imel, Michael J. Tanana, Sean Soth, Esther Ricardo-Bulis and David C. Atkins
    Citation: Addiction Science & Clinical Practice 2024 19:8
  46. Buprenorphine is a highly effective medication for opioid use disorder that is underused by health care professionals (HCPs). Medications for opioid use disorder (MOUD) misinformation may be an important barri...

    Authors: Berkeley Franz, Lindsay Y. Dhanani, O. Trent Hall, Daniel L. Brook, Cheyenne Fenstemaker, Janet E. Simon and William C. Miller
    Citation: Addiction Science & Clinical Practice 2024 19:7
  47. Nicotine replacement therapy (NRT) and short messaging service (SMS)-based tobacco cessation interventions have demonstrated effectiveness in reducing tobacco use in many populations, but evidence is needed on...

    Authors: Heather Wipfli, Jim Arinaitwe, Fastone Goma, Lynn Atuyambe, David Guwatudde, Masauso Moses Phiri, Elizeus Rutebemberwa, Fred Wabwire-Mangen, Richard Zulu, Cosmas Zyambo, Kyra Guy, Ronald Kusolo, Musawa Mukupa, Ezekiel Musasizi and Joan S. Tucker
    Citation: Addiction Science & Clinical Practice 2024 19:6

Affiliated with

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.7
    5-year Journal Impact Factor: 4.2
    Source Normalized Impact per Paper (SNIP): 1.062
    SCImago Journal Rank (SJR): 1.307

    Speed 2023
    Submission to first editorial decision (median days): 28
    Submission to acceptance (median days): 202

    Usage 2023
    Downloads: 755,413
    Altmetric mentions: 622

Archival content

Addiction Science & Clinical Practice was formerly published by NIDA and previous issues of the journal can be viewed here.